Search research articles
Contact Us
Filters
Showing results (181-190 of 294) with videos related to
Page
of 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2010
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab
Paul N Meyer, Kai Fu, Timothy C Greiner, et al.
Plos One
|
October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Lars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Leukemia
|
August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Ciara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Cancer Discovery
|
September 26, 2014
Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation
Kristina Heinig, Marcel Gätjen, Michael Grau, et al.
Nuklearmedizin. Nuclear Medicine
|
January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf Werner, Alexander Haug, Christian Buske, et al.
Nature
|
January 2, 2009
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival
Nicolas Bidère, Vu N Ngo, Jeansun Lee, et al.
Genome Medicine
|
June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
I-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Translational Oncology
|
August 21, 2018
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
Torsten Kessler, Ariane Baumeier, Caroline Brand, et al.
Blood Advances
|
December 18, 2025
Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden
Vanja Zeremski, Enver Aydilek, Akhil Behringer, et al.
Oncotarget
|
October 15, 2016
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
Janine Stucke-Ring, Julian Ronnacker, Caroline Brand, et al.
Page
of 30
Search research articles
Search
Showing results (181-190 of 294) with videos related to
Sort By:
Page
of 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2010
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab
Paul N Meyer, Kai Fu, Timothy C Greiner, et al.
Plos One
|
October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Lars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Leukemia
|
August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Ciara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Cancer Discovery
|
September 26, 2014
Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation
Kristina Heinig, Marcel Gätjen, Michael Grau, et al.
Nuklearmedizin. Nuclear Medicine
|
January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf Werner, Alexander Haug, Christian Buske, et al.
Nature
|
January 2, 2009
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival
Nicolas Bidère, Vu N Ngo, Jeansun Lee, et al.
Genome Medicine
|
June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
I-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Translational Oncology
|
August 21, 2018
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
Torsten Kessler, Ariane Baumeier, Caroline Brand, et al.
Blood Advances
|
December 18, 2025
Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden
Vanja Zeremski, Enver Aydilek, Akhil Behringer, et al.
Oncotarget
|
October 15, 2016
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
Janine Stucke-Ring, Julian Ronnacker, Caroline Brand, et al.
Page
of 30